✦ LIBER ✦

What dose of recombinant activated factor VII should be used in patients with factor XI deficiency?

✍ Scribed by S. A. Brown

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term follow-up of prophylaxis with

✍ B. JENABALI JAHROMI; M. KARIMI 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB

The use of recombinant activated factor

✍ Weei-Yuarn Huang; Margot S. Kruskall; Kenneth A. Bauer; Lynne Uhl; Beth H. Shaz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 125 KB

Low-dose recombinant activated factor VI

✍ Graciela Bauzá; Erwin Hirsch; Peter Burke; Karen Quillen 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Successful prophylaxis against intracran

✍ R. A. FARAH; D. HAMOD; N. MELICK; M. GIANSILY-BLAIZOT; S. SALLAH 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

The use of activated recombinant coagula

✍ R. González-Boullosa; R. Ocampo-Martínez; M. J. Alarcón-Martín; M. Suárez-Rodríg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Successful use of recombinant factor VII

✍ G. DELIOS; B. POLLIO; M. TUCCIARONE; G. AITORO; A. BORCHIELLINI; P. SCHINCO; M. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 48 KB